1. Home
  2. KR vs RMD Comparison

KR vs RMD Comparison

Compare KR & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kroger Company (The)

KR

Kroger Company (The)

SELL

Current Price

$69.27

Market Cap

34.9B

ML Signal

SELL

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$233.58

Market Cap

33.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KR
RMD
Founded
1883
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.9B
33.6B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
KR
RMD
Price
$69.27
$233.58
Analyst Decision
Buy
Buy
Analyst Count
24
20
Target Price
$69.00
★ $265.11
AVG Volume (30 Days)
★ 6.7M
1.3M
Earning Date
12-03-2026
10-29-2026
Dividend Yield
★ 2.26%
1.10%
EPS Growth
N/A
★ 9.67
EPS
2.51
★ 2.92
Revenue
★ $147,642,000,000.00
$2,957,013,000.00
Revenue This Year
$2.12
$3.23
Revenue Next Year
$1.59
$6.40
P/E Ratio
★ $27.48
$82.37
Revenue Growth
0.35
★ 13.44
52 Week Low
$54.15
$180.27
52 Week High
$76.58
$277.67

Technical Indicators

Market Signals
Indicator
KR
RMD
Relative Strength Index (RSI) 66.23 52.73
Support Level $65.34 $217.41
Resistance Level $72.45 $242.40
Average True Range (ATR) 1.66 7.05
MACD 0.23 -2.00
Stochastic Oscillator 93.90 55.69

Price Performance

Historical Comparison
KR
RMD

About KR Kroger Company (The)

Founded in 1883, Kroger is the largest pure-play supermarket operator in the United States, operating roughly 2,700 stores across more than 30 banners. Kroger's business is primarily grocery-led (roughly 79% of sales), spanning fresh food and private-label offerings, complemented by fuel centers (9%) and pharmacies (12%). The firm also generates income from advertising, data analytics, and manufacturing.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: